Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Abvc Biopharma (ABVC) over the last 13 years, with Q3 2025 value amounting to 0.02.

  • Abvc Biopharma's Asset Utilization Ratio fell 6403.88% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 6403.88%. This contributed to the annual value of 0.07 for FY2024, which is 28216.82% up from last year.
  • Abvc Biopharma's Asset Utilization Ratio amounted to 0.02 in Q3 2025, which was down 6403.88% from 0.0 recorded in Q2 2025.
  • Abvc Biopharma's Asset Utilization Ratio's 5-year high stood at 0.11 during Q1 2023, with a 5-year trough of 0.02 in Q1 2022.
  • In the last 5 years, Abvc Biopharma's Asset Utilization Ratio had a median value of 0.02 in 2025 and averaged 0.04.
  • Over the last 5 years, Abvc Biopharma's Asset Utilization Ratio had its largest YoY gain of 27238163533.27% in 2022, and its largest YoY loss of 13056.76% in 2022.
  • Over the past 5 years, Abvc Biopharma's Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then surged by 272381635.33% to 0.1 in 2022, then tumbled by 86.47% to 0.01 in 2023, then soared by 408.52% to 0.07 in 2024, then crashed by 65.17% to 0.02 in 2025.
  • Its Asset Utilization Ratio was 0.02 in Q3 2025, compared to 0.0 in Q2 2025 and 0.02 in Q1 2025.